Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 12,778 | 12,082 | 10,079 | 8,418 | 6,254 |
| Operating Income | -12,778 | -12,082 | -10,079 | -8,418 | -6,254 |
| Other Income | 10,571 | 3,025 | 6,667 | 4 | -3,500 |
| Pre-tax Income | -2,207 | -9,057 | -3,412 | -8,414 | -9,754 |
| Net Income Continuous | -2,207 | -9,057 | -3,412 | -8,414 | -9,754 |
| Net Income | $-2,207 | $-9,057 | $-3,412 | $-8,414 | $-9,754 |
| EPS Basic Total Ops | -0.60 | -2.50 | -6.90 | -40.00 | -49.20 |
| EPS Basic Continuous Ops | -0.61 | -2.50 | -6.87 | -39.97 | -49.24 |
| EPS Diluted Total Ops | -0.60 | -2.50 | -6.90 | -40.00 | -49.20 |
| EPS Diluted Continuous Ops | -0.61 | -2.50 | -6.87 | -39.97 | -49.24 |
| EBITDA(a) | $-12,562 | $-11,888 | $-9,947 | $-8,389 | $-6,232 |